George Yancopoulos, Bd. Co-Chair, President & CSO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100,000 shares at $972.22 ($97.3M) on 2024-05-16, disclosed to the SEC on 2024-05-17.
Scheduled sale ($97.3M) by Bd. Co-Chair, President & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $967.40 | 907 | $877K | 0.9% |
| 2 | $967.40 | 907 | $877K | 0.9% |
| 3 | $968.44 | 3,213 | $3.1M | 3.2% |
| 4 | $968.44 | 3,213 | $3.1M | 3.2% |
| 5 | $969.39 | 9,501 | $9.2M | 9.5% |
| 6 | $969.39 | 9,501 |
| $9.2M |
| 9.5% |
| 7 | $970.26 | 4,669 | $4.5M | 4.7% |
| 8 | $970.26 | 4,669 | $4.5M | 4.7% |
| 9 | $971.56 | 4,922 | $4.8M | 4.9% |
| 10 | $971.56 | 4,922 | $4.8M | 4.9% |
| 11 | $972.22 | 790 | $768K | 0.8% |
| 12 | $972.22 | 790 | $768K | 0.8% |
| 13 | $973.80 | 2,653 | $2.6M | 2.7% |
| 14 | $973.80 | 2,653 | $2.6M | 2.7% |
| 15 | $974.51 | 7,611 | $7.4M | 7.6% |
| 16 | $974.51 | 7,611 | $7.4M | 7.6% |
| 17 | $975.48 | 9,242 | $9.0M | 9.3% |
| 18 | $975.48 | 9,242 | $9.0M | 9.3% |
| 19 | $976.52 | 4,886 | $4.8M | 4.9% |
| 20 | $976.52 | 4,886 | $4.8M | 4.9% |
| 21 | $977.38 | 1,227 | $1.2M | 1.2% |
| 22 | $977.38 | 1,227 | $1.2M | 1.2% |
| 23 | $978.18 | 379 | $371K | 0.4% |
| 24 | $978.18 | 379 | $371K | 0.4% |
| Total | $972.73 avg | 100,000 | $97.3M | 100% |
| Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |
| REGN | SELL | 2021-08-17 | $62.0M | — | Filing → |